Search Results for “New LFCA Test Score Report Free PDF | Valid LFCA Test Questions: Linux Foundation Certified IT Associat 🥅 Search on ⏩ www.pdfvce.com ⏪ for ⇛ LFCA ⇚ to obtain exam materials for free download 🌱LFCA Vce Exam” – Page 31

High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study

Siebenhaar, F., Degener, F., Zuberbier, T., Martus, P., and Maurer, M.+: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J. Allergy Clin. Immunol. 2009: 123; 672-679. IF: 9.16

Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study

128

Ngouateu, O. B., Kollo, P., Ravel, C., Derreure, J., Kamtchouing, P., Same-Ekobo, A., von Stebut, E., Maurer, M. and Dondji, B.+: Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: Results of a large cross-sectional study. T. Roy. Soc. Trop. Med. H. 2012: 106; 137-142. IF: 1.82

Cutaneous manifestations in mastocytosis: consensus report of the European Competence Network on Mastocytosis (ECNM), AAAAI and EAACI

230

Hartmann, K.+, Escribano, L., Grattan, C., Brockow, K., Carter, M. C., Alvarez-Twose, I., Matito, A., Broesby-Olsen, S., Siebenhaar, F., Lange, M., Niedoszytko, M., Castells, M., Oude Elberink, J. N. G., Bonadonna, P., Zanotti, R., Hornick, J. L., Torrelo, A., Grabbe, J., Rabenhorst, A., Nedoszytko, B., Butterfield, J. H., Gotlib, J., Reiter, A., Radia, D., Hermine, O., Sotlar, K., George, T. I., Kristensen, T. K., Kluin-Nelemans, H. C., Yavuz, S., Hägglung, H., Sperr, W. R., Schwartz, L. B., Triggiani, M., Maurer, M. Nilsson, G., Horny, H. P., Arock, M., Orfao, A., Metcalfe, D. D., Akin, C., and Valent, P.: Cutaneous manifestations in mastocytosis: consensus report of the European Competence Network on Mastocytosis (ECNM), AAAAI and EAACI. J. Allergy Clin. Immunol. 2016: 137; p35-45. IF: 13.08

61.	Metz, M. and Maurer, M.: Omalizumab in chronic urticaria. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 406-411. IF: 3.39

3.	Tokura, Y., Röcken, M., Clark, R. A. F., Maurer, M., Grabbe, S., Haliasos, E., Takigawa M., and Sinha, A. A.: What are the most promising strategies for the therapeutic immunomodulation of allergic diseases? Exp. Dermatol. 2001: 11; 128-140. IF: 2.23

146	Maurer, M.+ Aberer, W., Bouillet, L., Caballero, T., Fabien, V., Kanny, G., Kaplan, A., Longhurst, H., and Zanichelli, A.: Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 2013: 8; e53773. IF: 3.53

o.146

29	Peters, E. M., Tobin, D. J., Botchkareva, N., Maurer, M. and Paus, R.⁺: Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J. Histochem. Cytochem. 2002: 50; 751-766. IF: 1.15

o.029

155	Cai, Y., Folkerts, J., Folkerts, G., Maurer, M., and Braber, S.+: Microbiota-dependent and –independent effects of dietary fiber on human health. Brit. J. Pharmacol. 2020: 177; 1363-1381. IF: 8.74

r.155

128.	Bygum, A., Busse, P., Caballero, T., and Maurer, M.+: Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema. Front. Med. 2017: 4; 212. IF: : 2.03

261	Staubach, P., Metz, M., Chapman-Rothe, N., Sieder, C., Bräutigam, M., Canvin, J., and Maurer, M.+: Effect of omalizumab on angioedema in H1-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial. Allergy 2016: 71; 1135-1144. IF: 7.36

Results